Jenene Thomas | IR |
Jerry Jabbour | CEO |
Raphael Mannino | CSO |
Jason McCarthy | Maxim Group |
Julian Harrison | H.C. Wainwright |
Greetings, and welcome to the Matinas BioPharma Quarterly Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Jenene Thomas, Investor Relations for Matinas BioPharma.